Ingersoll Rand Inc. (IR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Ingersoll Rand is a global company with a revenue of $7.5 billion, an EBITDA margin of 27%, and a free cash flow margin of approximately 17% [4] - The company's market capitalization is $34 billion [4] - Since its IPO of Gardner Denver in 2017 and the acquisition of Ingersoll Rand in 2020, the total shareholder return has exceeded 330% [4] Life Science Technologies Platform - The presentation at the JPMorgan Healthcare Conference marks the first time Ingersoll Rand is presenting at this prestigious event [2] - The CEO, Vicente Reynal, emphasized the importance of the Life Science platform, which will be further detailed by Scott Watson, SVP and General Manager [2]